Update on clinical trials of intra-articular disease-modifying osteoarthritis drugs inducing cartilage regeneration.

Osteoarthritis is the most common degenerative joint disease affecting millions of people in the world and leading to disability. Currently, the only available treatments on the market are symptomatic therapies for pain and inflammation. There are no…

Preview only. Read the full abstract at the source